Nanoform 1-12/2020 report and new company near-term target introduced
Company Announcement Nanoform Finland Plc February 26, 2021 08:10 a.m. Finnish time / 07:10 a.m. Swedish time Nanoform 1-12/2020 report and new company near-term target introduced First GMP manufacturing campaign and first dosing in humans successfully completed, positive interim results from first clinical study announced, all near-term business targets set out in IPO achieved, ten new Small Molecule PoC projects started, four more non-GMP lines commissioned, first Biologics PoC project commenced and a new near-term business target introduced: “At least 3 new non-GMP lines